1. S. Dawar, N. Singh, R. K. Kanwar, R. L. Kennedy, R. N. Veedu, S. F. Zhou, et al. J. R. Kanwar, Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers, Drug discovery today, 18(2013), pp., 1292–1300.
2. H. M. Coley, Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer, Cancer treatment reviews, 34(2008), pp., 378–390.
3. G. Szakacs, M. D. Hall, M. M. Gottesman, A. Boumendjel, R. Kachadourian, B. J. Day, et al. A. Di Pietro, Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance, Chemical reviews, 114(2014), pp., 5753–5774.
4. J. L. Markman, A. Rekechenetskiy, E. Holler and J. Y. Ljubimova, Nanomedicine therapeutic approaches to overcome cancer drug resistance, Adv Drug Deliv Rev, 65(2013), pp., 1866–1879.
5. A. K. Iyer, A. Singh, S. Ganta and M. M. Amiji, Role of integrated cancer nanomedicine in overcoming drug resistance, Adv Drug Deliv Rev, 65(2013), pp., 1784–1802.